USPTO serial 76685718
CLIENT DELIGHT
Reviewed by CopyMark Law Group
Status 606
- Filing date
- Status date
- Registration date
- —
- Examiner
- RINGLE, JAMES W
- Law office
- INTENT TO USE SECTION
What this means
This page summarizes the public USPTO record for this serial number, including owners, goods and services, and prosecution history.
Need help with CLIENT DELIGHT?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Monitor this mark, or talk with CopyMark about this registration.
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Phoenixville, PA
Phoenixville, PA
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
William L. Klima
WILLIAM L. KLIMA Klima Law Offices, P.L.L.C.PO BOX 2855STAFFORD, VA 22555-2855UNITED STATESGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 042 | Research and development for new products for others; materials testing and analyzing; technology consultation and research in the fields of pharmaceuticals and healthcare, in particular in the areas of pharmaceuticals packaging, drug stabilization, special packaging materials, and specialty packaging for pharmaceutical products; laboratory research in the fields of pharmaceuticals and healthcare, in particular in the areas of pharmaceuticals packaging, drug stabilization, special packaging materials, and specialty packaging for pharmaceutical products; technology supervision and inspection in the fields of pharmaceuticals and healthcare, in particular in the areas of pharmaceuticals packaging, drug stabilization, special packaging materials, specialty packaging for pharmaceutical products, and product quality control; pharmaceuticals packaging design for others; consulting services in the field of pharmaceuticals packaging; scientific research; testing, inspection or research of pharmaceuticals for others; medical and scientific research, namely, conducting clinical trials; chemical research; chemical technology research; scientific research and development for others; conducting of feasibility studies in the field of pharmaceuticals; quality control for others | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Mar 8, 2010 | MAB6 | ABANDONMENT NOTICE MAILED - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Mar 8, 2010 | ABN6 | ABANDONMENT - NO USE STATEMENT FILED | The intent-to-use application was abandoned because no acceptable Statement of Use (or valid extension) was filed before the Notice of Allowance deadline expired. The application is dead unless revived within a limited window. |
| Aug 4, 2009 | NOAM | NOA MAILED - SOU REQUIRED FROM APPLICANT | A Notice of Allowance means your intent-to-use application cleared examination and opposition but is not registered yet. You must file a Statement of Use showing the mark in commerce, or request an extension, before the deadline — usually six months from the notice date. |
| May 12, 2009 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 22, 2009 | NPUB | NOTICE OF PUBLICATION | — |
| Apr 8, 2009 | PREV | LAW OFFICE PUBLICATION REVIEW COMPLETED | — |
| Apr 8, 2009 | CNEA | EXAMINERS AMENDMENT MAILED | — |
| Apr 7, 2009 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Apr 7, 2009 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Apr 7, 2009 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 28, 2009 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Mar 28, 2009 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 23, 2009 | FAXX | FAX RECEIVED | — |
| Sep 22, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Sep 20, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 1, 2008 | ACEC | AMENDMENT FROM APPLICANT ENTERED | — |
| Jul 1, 2008 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Jul 1, 2008 | ALIE | ASSIGNED TO LIE | — |
| Jun 30, 2008 | FAXX | FAX RECEIVED | — |
| Apr 15, 2008 | CNRT | NON-FINAL ACTION MAILED | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 14, 2008 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Apr 6, 2008 | DOCK | ASSIGNED TO EXAMINER | — |
| Jan 22, 2008 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jan 18, 2008 | NWAP | NEW APPLICATION ENTERED | — |